SANKI Co.,Ltd. – Trademark Portfolio

Entity Type: 99

SANKI Co.,Ltd. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 6 filings in this category. The portfolio also extends into Class 18 (Leather Goods) across 4 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include EGZR and EGOZARU.

34 Minamishinza,

Tsuyama-shi Okayama 708-0036

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

SANKI Co.,Ltd.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (6 filings)

Clothing, footwear, headgear

18
Leather Goods (6 filings)

Leather and imitations of leather; animal skins, hides; trunks and travelling bags

24
Fabrics (5 filings)

Textiles and textile goods; bed covers; table covers

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does SANKI Co.,Ltd. have?

SANKI Co.,Ltd. has 8 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned, 2 cancelled.

What trademark classes does SANKI Co.,Ltd. file in?

SANKI Co.,Ltd. files trademarks across 4 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 18 (Leather Goods), Class 24 (Fabrics), Class 3 (Cosmetics & Cleaning). Class 25 covers clothing, footwear, headgear.

What are SANKI Co.,Ltd.'s most well-known trademarks?

SANKI Co.,Ltd.'s registered trademark portfolio includes well-known marks such as EGZR and EGOZARU. These are among 4 currently registered trademarks in the portfolio.

What is SANKI Co.,Ltd.'s trademark registration success rate?

SANKI Co.,Ltd. has a 57% trademark registration rate, with 4 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.